HomeIKAP • FRA
add
Aurinia Pharmaceuticals Inc
Previous close
€7.77
Day range
€7.66 - €7.66
Year range
€4.36 - €9.73
Market cap
1.17B USD
Avg Volume
59.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 67.77M | 24.32% |
Operating expense | 46.94M | -6.87% |
Net income | 14.35M | 206.72% |
Net profit margin | 21.17 | 185.81% |
Earnings per share | 0.10 | 211.11% |
EBITDA | 16.64M | 251.27% |
Effective tax rate | 3.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 348.24M | 3.32% |
Total assets | 549.36M | -1.02% |
Total liabilities | 161.36M | -1.09% |
Total equity | 388.00M | — |
Shares outstanding | 143.18M | — |
Price to book | 2.87 | — |
Return on assets | 5.47% | — |
Return on capital | 6.34% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 14.35M | 206.72% |
Cash from operations | 17.03M | 228.26% |
Cash from investing | -10.57M | 46.34% |
Cash from financing | -2.72M | -16.72% |
Net change in cash | 3.74M | 110.58% |
Free cash flow | 7.46M | 252.35% |
About
Founded
2012
Headquarters
Website
Employees
300
